MEDIBANK BOARD CHANGES
Medibank today announced the appointment of Dr Tracey Batten as a non-executive director with effect from 28 August 2017.
Dr Batten is an experienced clinician with over 25 years of experience in the health system both in Australia and overseas.
She is currently the CEO of the Imperial College Healthcare NHS Trust and prior to this she was the CEO of St Vincent's Health Australia where she led the restructuring of a network of state based private and public hospitals into a successful national organisation. Dr Batten has previously held the roles of CEO of Eastern Health and Dental Health Services Victoria.
Dr Batten is a graduate of Melbourne University, and in addition to her medical degree, she has a Masters of Health Administration from the University of New South Wales and a Masters of Business Administration from Harvard Business School.
Medibank Chairman Elizabeth Alexander said the board was delighted to welcome Dr Batten to the board.
"We are very pleased that Tracey has accepted our invitation to join the board. Tracey is highly regarded and credentialed both in Australia and the UK and her extensive experience in the healthcare industry makes her an ideal candidate, as Medibank increasingly looks to build and strengthen relationships with healthcare providers and develop new capabilities in healthcare services to improve the health and wellbeing outcomes of our customers," Ms Alexander said.
This appointment is the result of non-executive director Dr Cherrell Hirst's decision to retire from the Medibank board.
"Cherrell has been a very important part of the Medibank board over the past 8 years. In particular she played a leading role in the oversight of clinical governance within Medibank. Cherrell's contribution has been invaluable and the board and I thank her for her contribution and wish her all the very best," Ms Alexander concluded.
These changes are effective from 28 August 2017.
For further information please contact:
Acting Divisional General Manager, External Affairs
M: +61 429 642 418
General Manager, Investor Relations
T: +61 3 8622 5834 | M: +61 410 728 427
Back to top